FP7
EUPATI
European Patients' Academy on Therapeutic Innovation
- Programme
- Seventh Framework Programme
- Started
- Ends
- Duration
- 60 months
- Total cost
- EUR 10,951,178
- EU contribution
- EUR 5,250,000
- Participants
- 31 from 12 countries
- Topic
- FP7_IMI-JU-03-2010-07
- Grant agreement
- 115334
Coordinated by Verband Forschender Arzneimittelhersteller Ev (DEGermany).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Verband Forschender Arzneimittelhersteller Ev | DEGermany | Coordinator | Not stated | PIC (1.00) |
| Amgen | BEBelgium | Participant | Not stated | PIC (1.00) |
| European Forum for Good Clinical Practice | BEBelgium | Participant | EUR 893,637 | PIC (1.00) |
| European Genetic Alliance Network | BEBelgium | Participant | EUR 301,155 | PIC (1.00) |
| European Organisation for Research and Treatment of Cancer Aisbl | BEBelgium | Participant | EUR 56,245 | PIC (1.00) |
| Forum Europeen des Patients - European Patients' Forum | BEBelgium | Participant | EUR 1,232,402 | PIC (1.00) |
| Janssen Pharmaceutica NV | BEBelgium | Participant | Not stated | PIC (1.00) |
| Ucb Biopharma | BEBelgium | Participant | Not stated | PIC (1.00) |
| DIA Europe GmbH | CHSwitzerland | Participant | EUR 738,610 | PIC (1.00) |
| Novartis Pharma AG | CHSwitzerland | Participant | Not stated | PIC (1.00) |
| Bayer Pharma AG | DEGermany | Participant | Not stated | PIC (1.00) |
| Boehringer Ingelheim Internationalgmbh | DEGermany | Participant | Not stated | PIC (1.00) |
| European Aids Treatment Group Ev | DEGermany | Participant | EUR 288,670 | PIC (1.00) |
| Merck Kommanditgesellschaft Auf Aktien | DEGermany | Participant | Not stated | PIC (1.00) |
| Kobenhavns Universitet | DKDenmark | Participant | EUR 162,028 | known name (0.95) |
| Novo Nordisk A/S | DKDenmark | Participant | Not stated | PIC (1.00) |
| Asociacion Nacional Empresarial de la Industria Farmaceutica | ESSpain | Participant | Not stated | PIC (1.00) |
| Esteve Pharmaceuticals, SA | ESSpain | Participant | Not stated | PIC (1.00) |
| Eurordis - Rare Diseases Europe | FRFrance | Participant | EUR 489,621 | PIC (1.00) |
| SARD | FRFrance | Participant | Not stated | PIC (1.00) |
| Eli Lilly and Company Ltd | GBUnited Kingdom | Participant | Not stated | PIC (1.00) |
| Glaxosmithkline Research & Development Limited | GBUnited Kingdom | Participant | Not stated | PIC (1.00) |
| The University of Manchester | GBUnited Kingdom | Participant | EUR 609,438 | known name (0.95) |
| Hibernia College | IEIreland | Participant | EUR 384,918 | PIC (1.00) |
| Irish Platform for Patients' Organisations Science and Industry Limited By Guarantee | IEIreland | Participant | EUR 93,276 | PIC (1.00) |
| Chiesi Farmaceutici SpA | ITItaly | Participant | Not stated | PIC (1.00) |
| The Employers' Union of Innovative Pharmaceutical Companies INFARMA (Związek Pracodawców Innowacyjnych Firm Farmaceutycznych) | PLPoland | Participant | Not stated | PIC (1.00) |
| Astrazeneca AB | SESweden | Participant | Not stated | PIC (1.00) |
| Bristol-Myers Squibb Company Corp | USUnited States | Participant | Not stated | PIC (1.00) |
| International Society for Pharmacoeconomics and Outcomes Research Inc | USUnited States | Participant | Not stated | PIC (1.00) |
| Merck Sharp & Dohme Corp | USUnited States | Participant | Not stated | PIC (1.00) |
Changes of the consortium
First seen on with 31 participants from 12 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.